Search details
1.
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Ann Neurol
; 91(1): 89-100, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34687063
2.
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.
Immunology
; 165(2): 250-259, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34775604
3.
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion.
Br J Cancer
; 127(9): 1595-1602, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35986086
4.
Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor.
Eur J Immunol
; 51(2): 331-341, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32920841
5.
VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium.
Nucleic Acids Res
; 48(D1): D1057-D1062, 2020 01 08.
Article
in English
| MEDLINE | ID: mdl-31588507
6.
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity.
Immunology
; 163(4): 389-398, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33638871
7.
Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells.
Br J Cancer
; 124(9): 1552-1555, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33674735
8.
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
J Biol Chem
; 294(52): 20246-20258, 2019 12 27.
Article
in English
| MEDLINE | ID: mdl-31619516
9.
TCR-induced alteration of primary MHC peptide anchor residue.
Eur J Immunol
; 49(7): 1052-1066, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31091334
10.
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion.
Cancer Immunol Immunother
; 69(10): 2063-2073, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32447412
11.
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design.
Cancer Immunol Immunother
; 68(2): 247-256, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30406375
12.
The Ussing chamber system for measuring intestinal permeability in health and disease.
BMC Gastroenterol
; 19(1): 98, 2019 Jun 20.
Article
in English
| MEDLINE | ID: mdl-31221083
13.
Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions.
Proc Natl Acad Sci U S A
; 113(20): 5682-7, 2016 May 17.
Article
in English
| MEDLINE | ID: mdl-27114505
14.
T-cell modulation by cyclophosphamide for tumour therapy.
Immunology
; 154(1): 62-68, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29460448
15.
Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.
PLoS Pathog
; 12(12): e1006050, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27926930
16.
Chronic infections with viruses or parasites: breaking bad to make good.
Immunology
; 150(4): 389-396, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28009488
17.
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report.
J Clin Immunol
; 42(1): 32-35, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34714497
18.
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.
J Immunol
; 195(12): 5827-36, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26553072
19.
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs.
J Immunol
; 194(1): 463-74, 2015 Jan 01.
Article
in English
| MEDLINE | ID: mdl-25452566
20.
Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides.
Eur J Immunol
; 45(2): 584-91, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25471691